Protective immunity induced in squirrel monkeys with recombinant apical membrane antigen-1 of Plasmodium fragile
- PMID: 7810803
- DOI: 10.4269/ajtmh.1994.51.711
Protective immunity induced in squirrel monkeys with recombinant apical membrane antigen-1 of Plasmodium fragile
Abstract
Saimiri sciureus boliviensis monkeys were immunized with the Plasmodium fragile form of the merozoite apical membrane antigen-1 produced using the baculovirus expression system and combined with Montanide ISA 720 adjuvant. Following three immunizations, monkeys were challenged with 10,000 P. fragile trophozoite parasites. Antibody titers determined by fluorescence microscopy indicated an enhanced response following the second immunization. Four of five control animals had parasite counts > 5% 18-26 days following challenge. Four of five immunized monkeys had reduced levels of maximum parasitemia or delays in accumulated parasite counts, suggestive of protection. Rechallenge of the animals with P. falciparum resulted in three of four adjuvant control animals developing patent parasitemia whereas none of five immunized animals were infected, suggesting some level of heterologous protection.
Similar articles
-
Efficacy of vaccines containing rhoptry-associated proteins RAP1 and RAP2 of Plasmodium falciparum in Saimiri boliviensis monkeys.Am J Trop Med Hyg. 2000 Apr;62(4):466-79. doi: 10.4269/ajtmh.2000.62.466. Am J Trop Med Hyg. 2000. PMID: 11220762
-
Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.Malar J. 2016 Mar 15;15:159. doi: 10.1186/s12936-016-1226-5. Malar J. 2016. PMID: 26975721 Free PMC article.
-
A Plasmodium vivax Plasmid DNA- and Adenovirus-Vectored Malaria Vaccine Encoding Blood-Stage Antigens AMA1 and MSP142 in a Prime/Boost Heterologous Immunization Regimen Partially Protects Aotus Monkeys against Blood-Stage Challenge.Clin Vaccine Immunol. 2017 Apr 5;24(4):e00539-16. doi: 10.1128/CVI.00539-16. Print 2017 Apr. Clin Vaccine Immunol. 2017. PMID: 28179404 Free PMC article.
-
Recombinant protein vaccines against the asexual blood stages of Plasmodium falciparum.Hum Vaccin. 2010 Jan;6(1):39-53. doi: 10.4161/hv.6.1.10712. Epub 2010 Jan 19. Hum Vaccin. 2010. PMID: 20061790 Review.
-
Apical membrane antigen 1: a malaria vaccine candidate in review.Trends Parasitol. 2008 Feb;24(2):74-84. doi: 10.1016/j.pt.2007.12.002. Epub 2008 Jan 15. Trends Parasitol. 2008. PMID: 18226584 Review.
Cited by
-
Purification, characterization, and immunogenicity of the refolded ectodomain of the Plasmodium falciparum apical membrane antigen 1 expressed in Escherichia coli.Infect Immun. 2002 Jun;70(6):3101-10. doi: 10.1128/IAI.70.6.3101-3110.2002. Infect Immun. 2002. PMID: 12011004 Free PMC article.
-
Generation of humoral immune responses to multi-allele PfAMA1 vaccines; effect of adjuvant and number of component alleles on the breadth of response.PLoS One. 2010 Nov 3;5(11):e15391. doi: 10.1371/journal.pone.0015391. PLoS One. 2010. PMID: 21082025 Free PMC article.
-
Mixed allele malaria vaccines: host protection and within-host selection.Vaccine. 2008 Nov 11;26(48):6099-107. doi: 10.1016/j.vaccine.2008.09.004. Epub 2008 Sep 18. Vaccine. 2008. PMID: 18804509 Free PMC article.
-
Evidence for an increased risk of transmission of simian immunodeficiency virus and malaria in a rhesus macaque coinfection model.J Virol. 2011 Nov;85(22):11655-63. doi: 10.1128/JVI.05644-11. Epub 2011 Sep 14. J Virol. 2011. PMID: 21917966 Free PMC article.
-
Long-term humoral and cellular immune responses elicited by a heterologous Plasmodium vivax apical membrane antigen 1 protein prime/adenovirus boost immunization protocol.Infect Immun. 2011 Sep;79(9):3642-52. doi: 10.1128/IAI.05048-11. Epub 2011 Jul 5. Infect Immun. 2011. PMID: 21730090 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical